GHRSGH Research PLC

NASDAQ · Pharmaceuticals · Pharmaceuticals

$18.81+44.30%Market cap903.77M
Latest Close
$18.81
30-Day Move
+44.3%
Market Cap
$904M
Shares Outstanding
62,030,000
P/B Ratio
2.82
ROE
-17.3%
NASDAQ:GHRSPharmaceuticals / PharmaceuticalsDelayed public snapshot

GH Research PLC

A read-only Alphactor snapshot forGH Research PLC. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.

Snapshot as of2026-04-23

Topline snapshot

Latest Close

$18.81

30-Day Move

+44.3%

Market Cap

$904M

Shares Outstanding

62,030,000

P/B Ratio

2.82

ROE

-17.3%

Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot

$18.81

+44.3%last 90 delayed daily bars

Market cap$904M

90D High

$24.66

90D Low

$12.04

Avg Volume

331,964

What stands out

GHRS is up 44.3% over the last 30 trading days shown on this page.

Latest operating income is $-61M, which helps anchor the headline ratios with an actual earnings figure.

Fundamentals snapshot

Latest Close

$18.81

30-Day Move

+44.3%

Market Cap

$904M

Shares Outstanding

62,030,000

P/B Ratio

2.82

ROE

-17.3%

ROA

-16.7%

Debt / Equity

0

Current Ratio

34.13

Latest Revenue

$0

Financial statement snapshot

Revenue

$0

Gross Profit

--

Operating Income

$-61M

Net Income

$-48M

Gross Margin

--

Net Margin

--

Current Ratio

34.13

Debt / Equity

0.00

Quality snapshot

Altman Z

63.30

Safe

Piotroski

4

Moderate (4-6)

Cash Conversion

0.90x

Rule of 40

--

Insufficient data

Annual financial history

Annual performance mix

PeriodRevenueOperating IncomeNet IncomeFree Cash Flow
2022-12-31$0$-31M$-22M$-26M
2023-12-31$0$-41M$-36M$-33M
2024-12-31$0$-50M$-39M$-42M
2025-12-31$0$-61M$-48M$-44M

After signup

The app opens the full statement deep dive

Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.

Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.

Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.

Sign up to open the full statements
Institutional holders snapshot

FMR LLC (Fidelity)

Filed 2026-02-17

$65M

-3.6%

Marshall Wace

Filed 2026-02-13

$3M

--

Citadel Advisors

Filed 2025-11-14

$1M

--

Goldman Sachs

Filed 2026-02-10

$1M

+631.3%

BlackRock

Filed 2024-08-13

$705,034

--

Geode Capital Management

Filed 2025-11-12

$509,723

+2.9%

Northern Trust

Filed 2025-08-13

$475,130

-0.9%

Premium previews

See where the deeper analysis goes next

Sign up free
Open a preview card to sample a premium module.

High-intent actions

What you can do after signup

Organic traffic stays on the free tier by default, but signing up lets you save work and continue exploring.

For informational and educational purposes only. Not financial advice. Learn more

For informational and educational purposes only. Not financial advice. Learn more
GHRS Stock Analysis | GH Research PLC | alphactor.ai